BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:As more ADCs receive Accelerated Approval and Fast Track Desig
 nation\, expediting the transition to the clinic becomes a strategic prio
 rity for developers. This underscores the growing need of having a manufa
 cturing processes in place to support fast acceleration. Furthermore\, as
  ADCs progress into later stages\, establishing a robust process for guar
 antees product quality at a commercial scale becomes a high priority.\n\n
 The inaugural ADC Process Development Summit is the ultimate platform to 
 gain a comprehensive knowledge on the distinctive process development cha
 llenges unique to ADCs. By uniting 60+ senior executives pioneering the s
 pace\, this 3-day meeting will equip you with the expertise needed to est
 ablish a high-quality process that meets shortened timelines.\n\nThrough 
 unravelling key technical insights ranging from\, discussing high quality
  and high yielding conjugation\, impurity purification\, drug product lyo
 philization and formulation\, and engaging in regulatory discussions\, th
 is meet will leave no aspect of ADC Process Development unexplored.\n\nUR
 Ls:Tickets:&nbsp\;https://go.evvnt.com/1780569-2?pid=185Brochure:&nbsp\;h
 ttps://go.evvnt.com/1780569-3?pid=185\n\nPrices:Drug Developer - Full Pac
 kage: Conference + Workshop Day: USD 4297.00\,Drug Developer - Conference
  Only: USD 2299.00\,Solution Provider - Full Package: Conference + Worksh
 op Day: USD 5297.00\,Solution Provider - Conference Only: USD 3799.00\n\n
 Speakers:&nbsp\;Laurie Milnar\, Principal Research Scientist\, AbbVie\, S
 unny Zhang\, Senior Director\, Pharmaceutical Development\, ADC Therapeut
 ics\, Hayley Jackman\, Associate Director\, CMC Regulatory Affairs\, Astr
 aZeneca\, Ahmed Bassyouni\, Principal Consultant\, Bassyouni Consulting\,
  Michael Adamo\, Associate Director\, Bristol Myers Squibb\, Weijun Li\, 
 Senior Director\, Biologics Analytical Developmen\, &nbsp\;Exelixis\, Bra
 ndon Coyle\, Senior Research Scientist II\, Purification &nbsp\;Gilead\, 
 Christian Lutz\, Director\, Project Management\, Chemistry\, Manufacturin
 g and Controls\, Heidelberg Pharma Research\, Daniel Milano\, Senior Dire
 ctor\, Process Development\, Immunogen\, Sagit Hindi\, Associate Director
 \, Janssen\, Xiaolin Zhang\, Associate Principal Scientist\, Biologics Pr
 ocess\, R and D &nbsp\;Merck and Co\, Yogita Krishnamachari\, Director\, 
 Merck and Co\, Philip Kuhl\, Distinguished Scientist\, Bioconjugation and
  Chemistry Commercialization\, Merck and Co\, Vimal Patel\, Vice Presiden
 t\, Head of CMC\, Orum Therapeutics\, Megan Long\, Manufacturing Purifica
 tion Manager\, Seagen\, Anthony Colenburg\, Senior Director/Site Head of 
 Quality\, Sutro Biopharma\n\nTime:&nbsp\;9:00 am to 4:00 pm\n
DTEND:20230921T160000
DTSTAMP:20260512T234659Z
DTSTART:20230919T090000
LOCATION:The Bostonian\, 26\, North Street\, Boston\, Massachusetts\, 0210
 9\,
SEQUENCE:0
SUMMARY:As more ADCs receive Accelerated Approval and Fast Track Designati
 on\, expediting the transition to the clinic becomes a strategic priority
  for deve...
UID:7fe1c95f-ff7b-424d-8763-35d7e0c3791b
END:VEVENT
END:VCALENDAR